We have examined the mechanisms involved in the adherence of normal peripheral blood eosinophils to cultured human umbilical vein endothelial cells (HEC) under three conditions: (a) adherence in the absence of treatment of HEC or eosinophils with activating agents (basal adherence); (b) adherence induced by stimulation ofeosinophils with phorbol ester (eosinophil-dependent adherence); and (c) adherence induced by pretreatment of HEC with LPS, tumor necrosis factor (TNF), or IL-I (endothelial-dependent adherence). A mechanism was identified that was equally active in basal, eosinophil-dependent, and endothelial-dependent adherence. This mechanism was optimally active in the presence of both Ca"+ and Mg", and reduced in the presence of Ca"+ only or Mg"+ only. Furthermore, like the other mechanisms of eosinophil adherence, it was active at 370C but not at 4VC. A second mechanism of adherence was involved in eosinophil-and in endothelial-dependent adherence. This mechanism was dependent on the CD11/CD18 adhesion complex of eosinophils (i.e., inhibited by anti-CD18 
Mature eosinophils are located predominantly in the extravascular space, even in physiologic conditions (1) (2) (3) , the skin, gastrointestinal tract, and mucosa of the bronchi being the most heavily infiltrated tissues (3, 4) . Increased levels of circulating eosinophils and local accumulation of eosinophils at sites of acute or chronic inflammation have long been associated with allergic reactions, parasitic infestations, and other acute and chronic inflammatory diseases such as thyroiditis, some stages of tuberculosis, mycotic infections, recurrent staphylococcal infection, Hodgkin's disease, and other neoplastic processes (recently reviewed by Nutman et al. [5, 6] and by Spry [7] ). A series of studies has emphasized the role played in eosinophilmediated inflammatory reactions by powerful toxic mechanisms of eosinophils, such as the eosinophilic peroxidase-hydrogen peroxide-halide system (8) (9) (10) and the release of eosinophil major basic protein (1 1, 12) . In contrast, little is known about the mechanisms involved in the localization of eosinophils in tissues, both in physiologic and pathologic conditions. Eosinophil adherence to endothelial cells, a key event in leukocyte emigration into tissues (13) , was recently examined by Lamas et al. (14) and by Kimani et al. (15) . The authors have documented at least three mechanisms of eosinophil adherence to cultured human umbilical vein endothelial cells (HEC)': (a) adherence of unstimulated eosinophils to resting HEC (basal adherence); (b) adherence of eosinophils stimulated by chemotactic factors, such as platelet activating factor (PAF) (16, 17) , or by phorbol ester (PMA) to resting HEC (eosinophil-dependent adherence); and (c) adherence of resting eosinophils to HEC stimulated by cytokines, such as tumor necrosis factor (TNF) and IL-1, or LPS (endothelial-dependent adherence). The eosinophil-dependent adherence mechanism, similarto that of stimulated neutrophils (18, 19) , involves activation of the leukocyte adhesion complex CD 1 /CD 18, as judged by inhibition by CD18 MAb (14, 15) . Furthermore, as already reported for neutrophils (18, 19) , the endothelial-dependent adherence of eosinophils is only partially inhibited by CD 18 MAb, suggesting involvement of a second, CD1 8-independent adherence mechanism (15) . Finally, basal adherence ofeosinophils is independent ofCD1 1/CD 1 8 complex, since it is not affected by CDl1 /CD 1 8 MAb (14) .
In this paper we present evidence that several features of Immunofluorescenceflow cytometry. Immunofluorescence flow cytometry was performed as previously described (25) . Eosinophil and neutrophil preparations used in these assays were > 98% pure. Peripheral blood mononuclear cells were obtained by Ficoll-Hypaque separation. The cell populations comprised an average of 70% lymphocytes and 30% monocytes (29) . Leukocytes (5 X I05) were suspended in 50 Al PBS-0.1% BSA containing MAb P4C2 or MAb HP 2/1 (1:50 dilution of hybridoma supernatant media), MAb 60.3 or MAb 4B9 (20 jg/ml). The cells were incubated for 20 min at 4°C, washed free of unbound antibody, and incubated again at 4°C for 20 min with a 1:50 dilution of FITC goat anti-mouse IgG (Sigma). After washing, the cells were suspended in 500 jl of 1% paraformaldehyde in PBS and stored at 4°C. The mean fluorescence ofeach cell population was quantified by a flow cytometer (EPICS-C; Coulter Corp.; Hialeah, FL) with quantitative determination of peak fluorescence intensity. Monoclonal antibodies. MAb 60.3 is ofthe IgG2a subclass and recognizes the CD18 subunit (common beta-chain) of the CDI l/CD18 antigen complex (32) . MAb 4B9 is a murine IgGl and recognizes cells transfected with VCAM-I but not cells that are transfected with intercellular adhesion molecule-I (ICAM-1) or endothelial leukocyte adhesion molecule-l (ELAM-1) cDNA (23) . MAb BBl l is a murine IgG2b that recognizes a functional epitope on ELAM-l (33), and was a gift of Drs. Christopher Benjamin and Roy Lobb, Biogen Inc., Cambridge, MA. MAb P4C2 is a murine IgG3 that recognizes an epitope on CD49d and (34) and was a gift of Dr. Elizabeth Wayner, Cytel Corp., La Jolla, CA (34) . Monoclonal antibody HP2/1 is a murine IgG1 antibody that binds to an epitope on CD49d and was a gift of Dr. F. Sanchez-Madrid (35) . MAb P4CO is a murine IgG I that recognizes a functional epitope on CD29 (34), and was a gift of Dr. Elizabeth Wayner.
Reagents. Escherichia coli 055:B5 LPS, extracted by phenol/water, was obtained from Sigma Chemical Company. The LPS preparation was suspended in PBS at a concentration of 1.5 mg/ml, dispersed by sonication for 5 min at 4°C, and stored in aliquots at -35°C until used. Phorbol-12-myristate-13 acetate (PMA; Sigma) was dissolved at 1 mg/ ml in DMSO (Eastman Kodak Co., Rochester, NY) and stored as stock solution at -350C. Purified recombinant human IL-1 alpha (1,000 U/ml) (IL-1) was purchased from Boehringer Mannheim GmbH, Mannheim, FRG. Human recombinant TNF-alpha was a generous gift of Prof. R. Lax, Bissendorf Biochemicals GmbH, Hannover, FRG.
Statistics. Significance was determined by paired, two-tailed t test.
Results
Influence ofanti-CD18, anti-VCAM-J, and anti-ELAM-J MAb on eosinophil adherence to HEC. (Table III) .
Influence oftemperature on eosinophil adherence to HEC.
Adherence assays were performed at 37°C or at 4°C (Fig. 1 Table I and Fig. 1 were performed in PBS medium containing both Ca" (1 mM) and Mg++ (1 mM). Divalent cation requirements for the various mechanisms of adherence were further investigated in greater detail at 370C (Fig. 2) . Detachment ofHEC occurred in the absence ofboth calcium and magnesium, or in the presence of EDTA (1 mM), thereby preventing us from determining eosinophil adherence to HEC under these conditions. When the assay was performed in the presence ofCa++ only (1 mM), a In the presence ofMg"+ only (1 mM), unstimulated eosinophil adherence was similar to that observed in the presence of Ca`+ only. Eosinophil adherence to LPS-pretreated HEC, however, was significantly increased as compared to adherence to untreated HEC and was completely inhibited by MAb 60.3. Furthermore, in the presence of Mg"+ only, PMA stimulated eosinophil adherence and this was again inhibited by MAb 60.3. These results indicate that, in the presence of Mg`+ only, eosinophil adherence due to LPS pretreatment of HEC or to PMA is accounted for, almost completely, by CDl 1/CD 18. Raising Mg`+ concentration to 2 mM did not lead to appreciable changes in the results obtained with 1 mM Mg`+ (not shown).
In the presence of both Ca++ and Mg++, unstimulated eosinophil adherence was statistically greater than in the presence of Ca++ only or Mg++ only (Fig. 2) . Adherence to LPS-treated HEC was further increased above levels ofunstimulated adherence in the presence of Ca" and Mg", or levels of adherence to LPS-treated HEC in the presence of Mg++ only, and was only partially inhibited by MAb 60.3 (see also Table I ). In contrast, PMA-stimulated adherence of eosinophils in the presence ofCa++ and Mg++ was similar to that observed with Mg++ only, and was completely inhibited by the CD18 mAb 60.3.
Influence ofPMA on CDI I/CDJ8-dependent and -independent adherence mechanisms. In a previous study, we found that neutrophil CDl 1/CD18-independent adherence is downregulated when neutrophils are activated with PMA (25) . To define the effect ofphorbol ester on CDl 1/CD18-independent adherence of eosinophils, eosinophil adherence to HEC or LPStreated HEC was stimulated with PMA in the presence of the CD 18 (MAb) 60.3. As shown in Fig. 3 (18, 19) . However, neutrophils fail to accumulate in infected tissues in LAD patients (41) .
Since the CDl 1/CD 18-independent adherence mechanism of LAD neutrophils is inhibited in vitro when the neutrophils are activated by agents such as PMA or FMLP, and in this condition they do not adhere to stimulated HEC (25) , a possible explanation for the behavior of neutrophils in LAD patients is that, in vivo, the CDl l/CD18-independent adherence mechanism is downregulated by inflammatory stimuli produced at sites of inflammation (25, 40) . The absence of downregulation of eosinophil CDl 1/CD1 8-independent adherence mechanism may then account for eosinophil adherence to and migration across the endothelium in LAD patients, given that LAD eosinophils are endowed with the same CD 1 /CD 18-independent mechanisms of adherence as normal eosinophils.
